Garry Cooper - Publications

Physiology and Chemistry Northwestern University, Evanston, IL 
LTCC pharmacology in PD

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Cooper G, Kang S, Perez-Rosello T, Guzman JN, Galtieri D, Xie Z, Kondapalli J, Mordell J, Silverman RB, Surmeier DJ. A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of Ca1.3 L-Type Calcium Channels. Acs Chemical Biology. PMID 32881483 DOI: 10.1021/acschembio.0c00577  0.52
2015 Cooper G, Lasser-Katz E, Simchovitz A, Sharon R, Soreq H, Surmeier DJ, Goldberg JA. Functional segregation of voltage-activated calcium channels in motoneurons of the dorsal motor nucleus of the vagus. Journal of Neurophysiology. 114: 1513-20. PMID 26156385 DOI: 10.1152/jn.00432.2014  0.8
2015 Xu W, Hong SJ, Zeitchek M, Cooper G, Jia S, Xie P, Qureshi HA, Zhong A, Porterfield MD, Galiano RD, Surmeier DJ, Mustoe TA. Hydration status regulates sodium flux and inflammatory pathways through epithelial sodium channel (ENaC) in the skin. The Journal of Investigative Dermatology. 135: 796-806. PMID 25371970 DOI: 10.1038/jid.2014.477  0.8
2013 Kang S, Cooper G, Dunne SF, Luan CH, James Surmeier D, Silverman RB. Antagonism of L-type Ca2+ channels CaV1.3 and CaV1.2 by 1,4-dihydropyrimidines and 4H-pyrans as dihydropyridine mimics. Bioorganic & Medicinal Chemistry. 21: 4365-73. PMID 23688558 DOI: 10.1016/j.bmc.2013.04.054  0.8
2013 Kang S, Cooper G, Dunne SF, Luan CH, Surmeier DJ, Silverman RB. Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as Ca(V)1.3 calcium channel-selective antagonists for Parkinson's disease. Journal of Medicinal Chemistry. 56: 4786-97. PMID 23651412 DOI: 10.1021/jm4005048  0.8
2012 Kang S, Cooper G, Dunne SF, Dusel B, Luan CH, Surmeier DJ, Silverman RB. CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease. Nature Communications. 3: 1146. PMID 23093183 DOI: 10.1038/ncomms2149  0.8
Show low-probability matches.